Intranasal Anticholinergic Therapy of Rhinorrhea

Overview

Journal J Allergy Clin Immunol

Specialty Allergy & Immunology

Date 1992 Dec 1

PMID 1460208

Citations 4

Authors

E O Meltzer

Affiliations

Soon will be listed here.

Abstract

This article reviews the role of anticholinergic therapy for the rhinorrhea that occurs in various rhinopathies, including irritant reactions, perennial nonallergic rhinitis, viral infection rhinitis, allergic rhinitis, and temperature-induced rhinitis. The use of a topical anticholinergic medication, ipratropium bromide, and its ability to inhibit methacholine and rhinitis-induced hypersecretion is emphasized. Ipratropium bromide appears to be both safe and effective in reducing this troublesome symptom.

Citing Articles

Rational use of mucoactive medications to treat pediatric airway disease.

Linssen R, Ma J, Bem R, Rubin B Paediatr Respir Rev. 2020; 36:8-14.

PMID: 32653467 PMC: 7297155. DOI: 10.1016/j.prrv.2020.06.007.

New guidelines for the treatment of seasonal allergic rhinitis.

Emeryk A, Emeryk-Maksymiuk J, Janeczek K Postepy Dermatol Alergol. 2019; 36(3):255-260.

PMID: 31333340 PMC: 6640027. DOI: 10.5114/ada.2018.75749.

Mucoactive drugs.

Balsamo R, Lanata L, Egan C Eur Respir Rev. 2010; 19(116):127-33.

PMID: 20956181 PMC: 9682576. DOI: 10.1183/09059180.00003510.

Therapeutic approaches to mucus hypersecretion.

Yuta A, Baraniuk J Curr Allergy Asthma Rep. 2005; 5(3):243-51.

PMID: 15842963 DOI: 10.1007/s11882-005-0044-6.